Mangoceuticals, Net Tangible Assets vs Total Current Liabilities Analysis
| MGRX Stock | 2.65 0.15 6.00% |
Mangoceuticals, Common financial indicator trend analysis is infinitely more than just investigating Mangoceuticals, Common recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mangoceuticals, Common is a good investment. Please check the relationship between Mangoceuticals, Common Net Tangible Assets and its Total Current Liabilities accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangoceuticals, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Net Tangible Assets vs Total Current Liabilities
Net Tangible Assets vs Total Current Liabilities Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mangoceuticals, Common Net Tangible Assets account and Total Current Liabilities. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Mangoceuticals, Common's Net Tangible Assets and Total Current Liabilities is 0.96. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Mangoceuticals, Common Stock, assuming nothing else is changed. The correlation between historical values of Mangoceuticals, Common's Net Tangible Assets and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Mangoceuticals, Common Stock are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Net Tangible Assets i.e., Mangoceuticals, Common's Net Tangible Assets and Total Current Liabilities go up and down completely randomly.
Correlation Coefficient | 0.96 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Total Current Liabilities
Total Current Liabilities is an item on Mangoceuticals, Common balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Mangoceuticals, Common Stock are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from Mangoceuticals, Common's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mangoceuticals, Common current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangoceuticals, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. Selling General Administrative is likely to rise to about 6.8 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 4.1 M in 2024.
| 2010 | 2023 | 2024 (projected) | Gross Profit | 4.9K | 431.5K | 240.0K | Total Revenue | 8.9K | 731.5K | 407.2K |
Mangoceuticals, Common fundamental ratios Correlations
Click cells to compare fundamentals
Mangoceuticals, Common Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.